Cargando…
重组人血管内皮抑制素在晚期肺鳞癌治疗中的临床应用
BACKGROUND AND OBJECTIVE: Squamous cell carcinoma (SCC) is a common pathological type of nonsmall cell lung cancer, and advanced lung SCC is incurable. Chemotherapy combined with anti-angiogenesis agents can prolong the patients' survival time. Te aim of the study was to analyze the efcacy and...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973421/ https://www.ncbi.nlm.nih.gov/pubmed/27760596 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.06 |
Ejemplares similares
-
晚期肺鳞癌的治疗
Publicado: (2016) -
晚期肺鳞癌患者肿瘤标志物测定的临床分析
Publicado: (2016) -
肺鳞癌的免疫治疗进展
Publicado: (2016) -
尼妥珠单抗联合化疗二线及以上治疗晚期肺鳞癌
Publicado: (2016) -
高龄肺鳞癌患者的临床病理特征
Publicado: (2016)